P366: ARE MINIMAL RESIDUAL DISEASE MEASUREMENTS AFTER CONSOLIDATION THERAPY USEFUL IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA?

• Janine Stutterheim,
• Rachella Van der Waarden,
• Hester de Groot-Kruseman,
• Edwin Sonneveld,
• Valerie De Haas,
• Ellen C Van der Schoot,
• Vincent van der Velden,
• Rana Dandis,
• Rob Pieters

Affiliations

Janine Stutterheim

1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Rachella Van der Waarden

1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Hester de Groot-Kruseman

1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Edwin Sonneveld

1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Valerie De Haas

1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Ellen C Van der Schoot

2 Sanquin Blood Supply, Amsterdam, The Netherlands

Vincent van der Velden

3 Erasmus MC, Rotterdam, The Netherlands

Rana Dandis

1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Rob Pieters

1 Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands